Location History:
- Newark, CA (US) (2021 - 2022)
- Sunnyvale, CA (US) (2006 - 2023)
- Thousand Oaks, CA (US) (2024)
Company Filing History:
7 out of 9 
5 out of 9 
3 out of 3 Years Active: 2006-2025
Title: The Innovative Contributions of Wim Van Schooten
Introduction
Wim Van Schooten is a prominent inventor based in Sunnyvale, CA, known for his significant contributions to the field of biotechnology. With a total of 17 patents to his name, he has made remarkable advancements in the development of therapeutic antibodies.
Latest Patents
Among his latest patents are the Anti-BCMA heavy chain-only antibodies, which include methods of making such antibodies, compositions, and their use in treating B-cell disorders characterized by the expression of BCMA. Additionally, he has developed heavy chain antibodies binding to CD19, known as Anti-CD19 heavy chain antibodies, which are also aimed at treating B-cell disorders characterized by the expression of CD19.
Career Highlights
Wim has worked with notable companies such as Teneobio, Inc. and Therapeutic Human Polyclonals Inc., where he has played a crucial role in advancing antibody therapies. His work has been instrumental in the development of innovative treatments for various B-cell disorders.
Collaborations
Wim has collaborated with talented individuals in the field, including Nathan D. Trinklein and Shelley Force Aldred, contributing to a dynamic research environment that fosters innovation.
Conclusion
Wim Van Schooten's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic approaches in treating B-cell disorders.